Amphotericin b: A novel class of antiscrapie drugs

Journal of Infectious Diseases

Volumn 160, Issue 5, 1989, Pages 795-802

  Pocchiari, Maurizio ^a,b   Casaccia, Patrizia ^a,b   Ladogana, Anna ^a,b  

^a UNIVERSITY OF SALENTO   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; MEPARTRICIN;

ANIMAL EXPERIMENT; CENTRAL NERVOUS SYSTEM; DOSE RESPONSE; HAMSTER; NONHUMAN; PRIORITY JOURNAL; SCRAPIE; VIRUS INFECTION;

EID: 84960586189     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/160.5.795     Document Type: Article

References (48)

1. Medoff G, Brajtburg J, Kobayashi GS, Bolard J. Antifungal agents useful in therapy of systemic fungal infections. Annu Rev Pharmacol Toxicol 1983;23:303-330
2. Bolard J. How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 1986;864:257-304
3. Borden EC, McBain JA, Martin J, Walker D. Augmentation in the infectivity of SV40 virus DNA by amphotericin B methyl ester. Arch Virol 1981;69:161-165
4. Alonso MA, Carrasco L. Selective inhibition of cellular pro tein synthesis by amphotericin B in EMC virus-infected cells. Virology 1981;114:247-251
5. Stevens NM, Engle CG, Fisher PB, Mechlinski W, Schaffner CP. In vitro antiherpetic activity of water-soluble amphotericin B methyl ester. Arch Virol 1975;48:391-394
6. Schaffner CP, Plescia OJ, Pontani D, Sun D, Thornton A, Pandey RC, Sarin PS. Antiviral activity of amphotericin B methyl ester: inhibition of HTLV-III replication in cell culture. Biochem Pharmacol 1986;35:4110-4113
7. Amyx H, Salazar AM, Gajdusek DC, Gibbs CJ Jr. Chemotherapeutic trials in experimental slow virus disease. Neurology 1984;34(Suppl 1):149
8. Pocchiari M, Schmittinger S, Masullo C. Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J Gen Virol 1987;68:219-223
9. Brown P. Biologic and chemotherapeutic forays into the field of unconventional viruses. In: De Clercq E, Walker RT, eds. Targets for the design of antiviral agents. New York: Plenum Press, 1984:131-157
10. Pocchiari M, Schmittinger S, Ladogana A, Masullo C. Effect of amphotericin B in intracerebrally scrapie inoculated hamster. In: Court LA, Dormont D, Kingsbury D, eds. Proceedings II symposium international sur les virus non- conventionnels du systeme nerveux central. Moisdom la Riviere, France: Abbay de Melleray, 1989 (in press)
11. Brunori M, Silvestrini MC, Pocchiari M. The scrapie agent and the prion hypothesis. Trends Biochem Sci 1988; 13:309-313
12. Kimberlin RH. Scrapie: how much do we really understand? Neuropathol Appl Neurobiol 1986;12:131-147
13. Fraser H, Dickinson AG. Pathogenesis of scrapie in the mouse:the role of the spleen. Nature 1970;226:462-463
14. Fraser H, Dickinson AG. Studies of the lymphoreticular system in the pathogenesis of scrapie: the role of spleen and thymus. J Comp Pathol 1978;88:563-573
15. Dickinson AG, Fraser H. Scrapie: effect of Dh gene on the incubation period of extraneurally injected agent. Heredity 1972;29:91-93
16. Brown P. Chemotherapy of unconventional virus infections of the central nervous system. In: Field HJ, ed. Antiviral agents: the development and assessment of antiviral chemotherapy. Vol II. Boca Raton, Fla: CRC Press, 1988:13-28
17. Ehlers B, Diringer H. Dextran sulphate 500 delays and prevents mouse scrapie by impairment of agent replication in spleen. J Gen Virol 1984;65:1325-1330
18. Kimberlin RH, Walker CA. Characteristics of a short incubation model of scrapie in the golden hamster. J Gen Virol 1977;34:295-304
19. Tweit RC, Pandey RC, Rinehart KL Jr. Characterization of the antifungal and antiprotozoal antibiotic partricin and structural studies on partricins A and B. J Antibiot 1982;35:997-1012
20. Dickinson AG, Meikle VMH, Fraser H. Genetical control of the concentration of ME7 scrapie agent in the brain of mice. J Comp Pathol 1969;79:15-22
21. Prusiner SB, Groth DF, Cochran SP, Masiarz FR, McKinley MP, Martinez HM. Molecular properties, partial purification, and assay by incubation period measurements of the hamster scrapie agent. Biochemistry 1980;19:4883-4891
22. Diringer H, Hilmert H, Simon D, Werner E, Ehlers B. To wards purification of the scrapie agent. Eur J Biochem 1983;134:555-560
23. Reed J, Muench H. A simple method of estimating fifty per cent endpoints. Am J Hyg 1938;27:493-497
24. Ehlers B, Randolph R, Diringer H. The reticuloendothelial system in scrapie pathogenesis. J Gen Virol 1984;65: 423-428
25. Farquhar CF, Dickinson AG. Prolongation of scrapie incubation period by an injection of dextran sulphate 500 within the month before or after infection. J Gen Virol 1986; 67:463-473
26. Kimberlin RH, Walker CA. Antiviral compound effective against experimental scrapie. Lancet 1979;2:591-592
27. Kimberlin RH, Walker CA. The antiviral compound HPA-23 can prevent scrapie when administered at the time of infection. Arch Virol 1983;78:9-18
28. Kimberlin RH, Walker CA. Suppression of scrapie infection in mice by heteropolyanion 23, dextran sulphate, and some other polyanions. Antimicrob Agents Chemother 1986; 30:409-413
29. Malone TG, Marsh RF, Hanson RP, Semancik JS. Membrane-free scrapie activity. J Virol 1978;25:933-935
30. Hogan RN, Baringer JR, Prusiner SB. Progressive retinal de generation in scrapie-infected hamsters. A light and electron microscopic analysis. Lab Invest 1981;44:34-42
31. Baringer JR, Bowman KA, Prusiner SB. Replication of scrapie agent in hamster brain precedes neuronal vacuolation. J Neuropathol Exp Neurol 1983;42:539-547
32. Czub M, Braig HR, Diringer H. Replication of the scrapie agent in hamsters infected intracerebrally confirms the pathogenesis of an amyloid-inducing virosis. J Gen Virol 1988;69:1753-1756
33. Moreau-Dubois MC, Brown P, Rohwer RG, Masters CL, Franco M, Gajdusek DC. Experimental scrapie in golden Syrian hamsters: temporal comparison of in vitro cell- fusing activity with brain infectivity and histopathologi- cal changes. Infect Immun 1982;37:195-199
34. Kimberlin RH, Walker CA. Pathogenesis of scrapie (strain 263K) in hamsters infected intracerebrally, intraperitoneally or intraocularly. J Gen Virol 1986;67:255-263
35. Prusiner SB. Prion diseases and central nervous system de generation. Clin Res 1987;35:177-191
36. Czub M, Braig HR, Diringer H. Pathogenesis of scrapie: study of the temporal development of clinical symptoms, of infectivity titres and scrapie-associated fibrils in brains of hamsters infected intraperitoneally. J Gen Virol 1986; 67:2005-2009
37. Manuelidis L, Sklaviadis T, Manuelidis EE. Evidence suggesting that PrP is not the infectious agent in Creutzfeldt- Jakob disease. EMBO J 1987;6:341-347
38. Gajdusek DC. Transmissible and nontransmissible dementias: distinction between primary cause and pathogenetic mechanisms in Alzheimer’s disease and aging. Mt Sinai J Med (NY) 1988;55:3-5
39. Niewold TA, Hoi PR, van Andel ACJ, Lutz ETG, Gruys E. Enhancement of amyloid induction by amyloid fibril fragments in hamster. Lab Invest 1987;56:544-549
40. Hope J, Multhaup G, Reekie L JD, Kimberlin RH, Beyereuther K. Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur J Biochem 1988;172:271-277
41. Bruzzese T, Dell’Acqua E, Bianchi C, Goi A, Racchelli L, Recusani F. A soluble mepartricin complex (SPA-S-222) of potential oral and parenteral utility in fungal and protozoal infections. II Farmaco 1976;31:291-296
42. Lawrence RM, Hoeprich PD, Jagdis FA, Monji N, Huston AC, Schaffner CP. Distribution of doubly radiolabelled amphotericin B methyl ester and amphotericin B in the non-human primate, Macaca mulatta. J Antimicrob Chemother 1980;6:241-249
43. Graybill JR, Craven PC, Taylor RL, Williams DM, Magee WE. Treatment of murine cryptococcosis with liposome- associated amphotericin B. J Infect Dis 1982;145:748-752
44. Szoka FC Jr, Milholland D, Barza M. Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B. Antimicrob Agents Chemother 1987;31:421-429
45. Kimberlin RH, Walker CA. Pathogenesis of mouse scrapie:dynamics of agent replication in spleen, spinal cord and brain after infection by different routes. J Comp Pathol 1979;89:551-562
46. Lin HS, Medoff G, Kobayashi GS. Effect of amphotericin B on macrophages and their precursor cells. Antimicrob Agents Chemother 1977;11:154-160
47. Marsh RF. Effect of vaccinia-activated macrophages on scrapie infection in hamsters. In: Streilen JW, Hart DA, Stein Streilen J, Duncan WR, Billingham RE, eds. Hamster immune response in infectious and oncologic diseases. New York, Plenum Press, 1981:359-363
48. Kimberlin RH, Cunnington PG. Reduction of scrapie incubation time in mice and hamsters by a single injection of methanol extraction residue of BCG. FEMS Microbiol Lett 1978;3:169-172